Cell Biotech Co. Ltd Strategic Asset Allocation Index
Cell Biotech Co. Ltd strategic asset allocation index. Cell Biotech Co. Ltd (049960) has a Strategic Asset Allocation Index of 24.2% as of March 2025. Strategic assets (PP&E of ₩29.77 Billion plus long-term investments of ₩-) total ₩29.77 Billion, measured against net assets of ₩123.28 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 049960 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cell Biotech Co. Ltd (2011–2024)
Strategic asset allocation index of Cell Biotech Co. Ltd from 2011 to 2024. This chart shows how Cell Biotech Co. Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2011 to 2024. As of March 2025, the index stands at 24.2%, representing strategic assets of ₩29.77 Billion against net assets of ₩123.28 Billion KRW.
Cell Biotech Co. Ltd Strategic Asset Allocation Index by Year (2011–2024)
Cell Biotech Co. Ltd strategic asset allocation index by year from 2011 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Cell Biotech Co. Ltd from 2011 to 2024, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Cell Biotech Co. Ltd.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 24.5% | ₩30.46 Billion | ₩30.46 Billion | ₩- | ₩124.17 Billion | ▼ -4.9 pp |
| 2023 | 29.4% | ₩32.94 Billion | ₩32.94 Billion | ₩- | ₩111.89 Billion | ▼ -1.7 pp |
| 2022 | 31.1% | ₩33.64 Billion | ₩33.64 Billion | ₩- | ₩108.09 Billion | ▼ -0.8 pp |
| 2021 | 31.9% | ₩34.06 Billion | ₩34.06 Billion | ₩- | ₩106.69 Billion | ▼ -4.7 pp |
| 2020 | 36.6% | ₩36.60 Billion | ₩36.60 Billion | ₩- | ₩99.98 Billion | ▲ +1.8 pp |
| 2019 | 34.8% | ₩36.07 Billion | ₩36.07 Billion | ₩- | ₩103.60 Billion | ▲ +7.7 pp |
| 2018 | 27.1% | ₩28.65 Billion | ₩28.65 Billion | ₩2.00 Million | ₩105.62 Billion | ▲ +1.1 pp |
| 2017 | 26.0% | ₩23.48 Billion | ₩23.18 Billion | ₩294.77 Million | ₩90.20 Billion | ▲ +2.5 pp |
| 2016 | 23.5% | ₩19.80 Billion | ₩19.52 Billion | ₩271.59 Million | ₩84.15 Billion | ▼ -4.9 pp |
| 2015 | 28.5% | ₩19.57 Billion | ₩18.78 Billion | ₩792.04 Million | ₩68.76 Billion | ▼ -5.5 pp |
| 2014 | 33.9% | ₩17.76 Billion | ₩16.77 Billion | ₩994.06 Million | ₩52.36 Billion | ▼ -6.3 pp |
| 2013 | 40.2% | ₩17.32 Billion | ₩16.46 Billion | ₩864.00 Million | ₩43.05 Billion | ▲ +6.5 pp |
| 2012 | 33.7% | ₩12.28 Billion | ₩10.94 Billion | ₩1.34 Billion | ₩36.42 Billion | ▲ +7.5 pp |
| 2011 | 26.3% | ₩8.34 Billion | ₩8.34 Billion | ₩- | ₩31.77 Billion | — |